p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; min-height: 14.0px} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.1px; font: 10.0px Helvetica; color: #00628f} p.p3 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.1px; font: 10.0px Helvetica; color: #686a6c} p.p4 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 10.1px; font: 10.0px Helvetica; color: #686a6c} span.s1 {font: 12.0px Helvetica; color: #000000}

The Situation:
When Johnson & Johnson (J&J) decided to purchase all of Pfizer’s consumer products, including the Efferdent brand, the multinational giant experienced for the first time the complicated intricacies of technology transfer for effervescent products.

The Challenge:
The Efferdent brand was being manufactured at a Pfizer facility in Puerto Rico, so J & J required a transfer of the assets to a supplier in its network. However, very few suppliers had a dedicated Technology Transfer Team capable of making the numerous transitions required, while simultaneously maintaining uninterrupted supply deliveries and keeping the process as seamless and precise as possible.